Google
ABEO — ABEONA THERAPEUTICS INC (Healthcare >> Biotechnology)
ABEO FAQ
What is ABEO's P/E ratio?
ABEONA THERAPEUTICS INC (ABEO) currently trades at a P/E ratio of 3.01.
What is ABEO's ROE?
ABEONA THERAPEUTICS INC reports a Return on Equity (ROE) of 45.63%.
What is ABEO's dividend yield?
ABEONA THERAPEUTICS INC offers a dividend yield of 0.00%.
What is ABEO's Deepscope Quality Score?
Deepscope rates ABEO's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ABEO?
Deepscope's AI Timing Score for ABEO is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ABEO belong to?
ABEONA THERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 5.82
Price
0.15
(2.65%)
Day Change
|
|
|---|
ABEO, ファンダメンタルスコアはok ( ファンダメンタル = 62) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROEの伸びが低い
平均ROEが低い
ROAの伸びが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are ok , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
64% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 92 |
| Magic Formula Rank by ROA |
47
GREAT
|
| Magic Formula Rank by ROE |
47
GREAT
|
| Magic Formula Rank by ROIC |
40
GREAT
|
| Price | 5.82 |
| PBV / Sector |
2.26 / 4.58
|
| Earning Per Share | 1.18 |
| PE / Sector |
3.01 / 17.10
GREAT
|
| PEG or PE/Growth / Sector |
-0.03 / 0.52
|
| Average 1M Daily Value |
5.92 M
GREAT
|
| Average 1W Daily Value |
4.28 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
60% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-05 09:12:37 |
| Symbol | ABEO |
| Name | ABEONA THERAPEUTICS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 57.00 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 327.15 / 8,655.90 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 6555 Carnegie Avenue, Cleveland, OH, United States, 44103
Phone: 646 813 4701
Website: https://www.abeonatherapeutics.com
Employees: 226
Sector: Healthcare >> Biotechnology
Description: Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
